NFKB1 and breast carcinoma: IKKα expression was associated mainly with ER-positive tumors, whereas IKBKβ, p50, and p65 from the canonical, and NIK, p52 and RELB from the alternative NF-κB pathway were associated with better RFS of breast cancer patients.